Pharma-major, Glenmark Pharmaceuticals Limited announced that it is concluding the final, national phase of its marketing approval application process to enable the launch of Ryaltris nasal spray in 17 countries in the European Union.  

Reliance Industries Limited (RIL) informed today that it has collaborated with BP, one of the world's seven oil & gas ‘supermajors’ and British multinational company to commence production from the Satellite Cluster Gas Field in block KG D6, off the east coast of India.  

Biocon Limited’s subsidiary Biocon Biologics Ltd has informed the bourses that Abevmy 100 & 400 mg, a biosimilar of Bevacizumab co-developed with Viatris Inc. has received marketing authorisation approval from European Commission (EC), following the positive recommendation by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency. 

Following the global trend of medication shifting from allopathy to herbal therapy in veterinary, Hester Biosciences announced on Saturday that it has embarked on a journey to produce research-based herbal products for livestock and poultry.  

On Friday, Alembic Pharmaceuticals informed the exchanges that it has received final approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Doxepin Hydrochloride capsules, in the strengths of 10 mg, 25 mg, 50 mg, 75 mg & 100 mg.  

What are the factors that impact the stock market? Know more in this article  on FAQs